Morishita Jintan Co., Ltd. (JP:4524)

:4524

4524

Morishita Jintan Co., Ltd.

RESEARCH TOOLSreports

Want to see JP:4524 full AI Analyst Report?

Morishita Jintan Co., Ltd. (4524) Price & Analysis

2 Followers

4524 Stock Chart & Stats

¥2187.00

¥4.00(0.19%)

At close: Jan 08 4:00 PM EST

¥2187.00

¥4.00(0.19%)

Day’s Range― - ―

52-Week Range¥2,091.00 - ¥2,390.00

Previous CloseN/A

Volume1.20K

Average Volume (3M)1.68K

Market Cap

¥8.90B

Enterprise Value¥8.79B

Total Cash (Recent Filing)¥1.13B

Total Debt (Recent Filing)¥1.33B

Price to Earnings (P/E)14.2

Beta0.33

Next Earnings

Aug 11, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield2.55%

Share Statistics

EPS (TTM)113.63

Shares Outstanding4,150,000

10 Day Avg. Volume1,530

30 Day Avg. Volume1,680

Financial Highlights & Ratios

PEG Ratio0.99

Price to Book (P/B)0.70

Price to Sales (P/S)0.72

P/FCF Ratio506.33

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetA strong equity base and historically low leverage provide a durable financial cushion against shocks and fund strategic choices. This conservatism supports dividend payments, withstands temporary cash gaps, and preserves the company's ability to invest selectively without forcing distressed financing.

Established Domestic Brand And DistributionWell-known flagship brands and entrenched retail channels create sustained demand and shelf presence in Japan's consumer healthcare market. Brand recognition and established distribution reduce customer acquisition costs and support steady retail sell-through, underpinning predictable revenue streams over time.

Improving Operating Cash GenerationA meaningful rebound in operating cash flow indicates the core business can generate cash when operations improve, enhancing liquidity for working capital, modest capex, and dividends. Sustained OCF strength would reduce reliance on external funding and improve financial flexibility.

Bears Say

Volatile Free Cash FlowIrregular free cash flow undermines the company's ability to fund discretionary activities like product development, marketing, or M&A without tapping reserves or increasing debt. Persistent FCF volatility raises execution risk and constrains long-term strategic investments and payout consistency.

Top-line Softness In 2026A decline in revenue after prior growth suggests demand weakening or product cycle drag in core OTC categories. Prolonged top-line stagnation limits operating leverage benefits, pressures margins over time, and forces management to find structural growth avenues or accept slower earnings progression.

Rising Debt LevelAn increase in total debt, even from a low base, raises fixed obligations and reduces balance sheet optionality. If cash generation remains uneven, higher leverage could constrain investment choices, limit defensive flexibility in downturns, and require tighter capital allocation discipline going forward.

4524 FAQ

What was Morishita Jintan Co., Ltd.’s price range in the past 12 months?

Morishita Jintan Co., Ltd. lowest stock price was ¥2091.00 and its highest was ¥2390.00 in the past 12 months.

What is Morishita Jintan Co., Ltd.’s market cap?

Morishita Jintan Co., Ltd.’s market cap is ¥8.90B.

When is Morishita Jintan Co., Ltd.’s upcoming earnings report date?

Morishita Jintan Co., Ltd.’s upcoming earnings report date is Aug 11, 2026 which is in 68 days.

How were Morishita Jintan Co., Ltd.’s earnings last quarter?

Morishita Jintan Co., Ltd. released its earnings results on May 13, 2026. The company reported ¥64.89 earnings per share for the quarter, beating the consensus estimate of N/A by ¥64.89.

Is Morishita Jintan Co., Ltd. overvalued?

According to Wall Street analysts Morishita Jintan Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Morishita Jintan Co., Ltd. pay dividends?

Morishita Jintan Co., Ltd. pays a Annually dividend of ¥65 which represents an annual dividend yield of 2.55%. See more information on Morishita Jintan Co., Ltd. dividends here

What is Morishita Jintan Co., Ltd.’s EPS estimate?

Morishita Jintan Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Morishita Jintan Co., Ltd. have?

Morishita Jintan Co., Ltd. has 4,150,000 shares outstanding.

What happened to Morishita Jintan Co., Ltd.’s price movement after its last earnings report?

Morishita Jintan Co., Ltd. reported an EPS of ¥64.89 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.825%.

Which hedge fund is a major shareholder of Morishita Jintan Co., Ltd.?

Currently, no hedge funds are holding shares in JP:4524

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Morishita Jintan Co., Ltd.

Morishita Jintan Co., Ltd. produces and distributes pharmaceuticals, quasi drugs, medical devices, and food products in Japan. It operates through Healthcare Business and Capsule Business divisions. The Healthcare Business division manufactures and sells Jintan branded products, as well as engages in OEM of dietary supplements, cosmetics, foods, etc. The Capsule Business division is involved in the OEM/ODM of pharmaceuticals, foods, etc., as well as the development of industrial use capsules. Morishita Jintan Co., Ltd. was founded in 1893 and is headquartered in Osaka, Japan.